scPharmaceuticals Inc. Quarterly Cost of Revenue in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
scPharmaceuticals Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2023 to Q3 2024.
  • scPharmaceuticals Inc. Cost of Revenue for the quarter ending September 30, 2024 was $3.31M, a 207% increase year-over-year.
  • scPharmaceuticals Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $9.17M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.17M $3.31M +$2.23M +207% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $6.94M $2.3M +$1.95M +550% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $4.99M $1.79M +$1.18M +195% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $3.81M $1.77M Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $1.08M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $354K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $605K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.